title: Association of humoral immunity to human Hsp60 with the IL-6 gene polymorphism C-174G in patients with type 2 diabetes and controls.
abstract: The relationship between humoral immunity to hsp60 and type 2 diabetes along with other relevant metabolic, inflammatory and immunogenetic variables was studied in 76 non-diabetic and 74 diabetic persons aged 55-74 years selected from the population-based KORA Survey 2000. Antibodies to human hsp60 were measured in serum samples by ELISA. Hsp60 antibodies were detected in all but two individuals in a considerable range of titres (22-1,856 AU/ml). There was no significant association to age and sex, or to key clinical or metabolic parameters (BMI, WHR, HbA1c, total cholesterol, LDL cholesterol, HDL cholesterol, systolic and diastolic blood pressure, albumin, uric acid) or immunological parameters (CRP, IL-6, sIL-6R, TNFalpha, sTNFalpha R60, sTNFalpha R80). Analysis of antibody-positive individuals revealed an association between hsp60 antibodies and diabetes at borderline significance (p = 0.047), which was lost when the two antibody-negative individuals were included. Genetic analyses indicated that this association was significant in carriers of the C allele of the IL-6 promoter region polymorphism at nucleotide -174 (p = 0.02), but not in GG genotype carriers. We conclude that humoral immunity to human hsp60 may be enhanced in those diabetic patients carrying the -174C allele of the IL-6 gene. This finding may contribute to an understanding of the relationship between the -174C allele and increased risk of atherosclerosis.
authors.affiliation: German Diabetes Clinic, German Diabetes Center, Leibniz Institute at the Heinrich-Heine-University, Düsseldorf, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Mostafazadeh
authors.forename: C
authors.initials: C
authors.lastname: Herder
authors.forename: B
authors.initials: B
authors.lastname: Haastert
authors.forename: P
authors.initials: P
authors.lastname: Hanifi-Moghaddam
authors.forename: N
authors.initials: N
authors.lastname: Schloot
authors.forename: W
authors.initials: W
authors.lastname: Koenig
authors.forename: T
authors.initials: T
authors.lastname: Illig
authors.forename: B
authors.initials: B
authors.lastname: Thorand
authors.forename: R
authors.initials: R
authors.lastname: Holle
authors.forename: M-B
authors.initials: MB
authors.lastname: Eslami
authors.forename: H
authors.initials: H
authors.lastname: Kolb
mesh_terms: D000368:Aged; D000917:Antibody Formation / Q000502:physiology*; D001323:Autoantibodies / Q000032:analysis*; D018834:Chaperonin 60 / Q000276:immunology*; D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics* / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005838:Genotype; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic / Q000235:genetics
chemical_list: D001323:Autoantibodies; D018834:Chaperonin 60; D015850:Interleukin-6; D004247:DNA